These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. [Determination of the histaminogenic action of pancuronium bromide in man]. Costa J; Neto O Rev Bras Anestesiol; 1971; 21(4):742-6. PubMed ID: 4111949 [No Abstract] [Full Text] [Related]
65. Neurosteroid analogues. 8. Structure-activity studies of N-acylated 17a-aza-D-homosteroid analogues of the anesthetic steroids (3alpha, 5alpha)- and (3alpha,5beta)-3-hydroxypregnan-20-one. Covey DF; Han M; Kumar AS; de La Cruz MA; Meadows ES; Hu Y; Tonnies A; Nathan D; Coleman M; Benz A; Evers AS; Zorumski CF; Mennerick S J Med Chem; 2000 Aug; 43(17):3201-4. PubMed ID: 10966737 [No Abstract] [Full Text] [Related]
66. [Clinical study of pancuronium bromide--cumulation effect and interaction with halothane]. Amaki Y; Uchida M; Kobayashi K Masui; 1972 Nov; 21(12):1227-31. PubMed ID: 4265509 [No Abstract] [Full Text] [Related]
67. [Comparative effects of heptaminol hydrochloride and acefyllinate on curarization]. Bouyard P; Mesdjian E; Balansard P; Jadot G C R Seances Soc Biol Fil; 1972; 166(4):662-6. PubMed ID: 4265545 [No Abstract] [Full Text] [Related]
68. [Effects of diallyl-nor-toxiferin and pancuronium bromide on the circulatory system]. Ogawa T; Takeyoshi S; Mori H Masui; 1973 Jun; 22(6):533-7. PubMed ID: 4269342 [No Abstract] [Full Text] [Related]
69. A comparison of some cardiovascular effects of tubocurarine and pancuronium in dogs. Smith G; Proctor DW; Spence AA Br J Anaesth; 1970 Nov; 42(11):923-7. PubMed ID: 4249791 [No Abstract] [Full Text] [Related]
70. Clinical comparison of tubocurarine and pancuronium. Joseph D; Bookallil M Anaesth Intensive Care; 1972 Aug; 1(1):75-8. PubMed ID: 4265997 [No Abstract] [Full Text] [Related]
71. Specific blockade of cardiac muscarinic receptors by pancuronium bromide. Saxena PR; Bonta IL Arch Int Pharmacodyn Ther; 1971 Feb; 189(2):410-2. PubMed ID: 4251351 [No Abstract] [Full Text] [Related]
72. A biomimetic approach to C-nor-D-homo-steroids. Heretsch P; Rabe S; Giannis A J Am Chem Soc; 2010 Jul; 132(29):9968-9. PubMed ID: 20597501 [TBL] [Abstract][Full Text] [Related]
73. Synthesis and cytotoxic activity of some 4,6-diaza-A,B-dihomo-steroid bilactams. Cui J; Lin Q; Gan C; Yao Q; Su W; Huang Y Steroids; 2014 Jan; 79():14-8. PubMed ID: 24200959 [TBL] [Abstract][Full Text] [Related]
74. A clinical comparison of pancuronium bromide with D-tubocurarine in adult Nigerian patients. Magbagbeola JA Can Anaesth Soc J; 1972 Nov; 19(6):615-22. PubMed ID: 4264105 [No Abstract] [Full Text] [Related]
75. The immediate cardiovascular effects of pancuronium. Downing JW; Leary WP; Coleman AJ; Moyes DG S Afr Med J; 1972 Jul; 46(28):962-6. PubMed ID: 4262468 [No Abstract] [Full Text] [Related]
77. Effects of pancuronium bromide on the motor nerve terminal. Dretchen KL; Sokoll MD; Gergis SD; Long JP Eur J Pharmacol; 1972 Oct; 20(1):46-51. PubMed ID: 4264266 [No Abstract] [Full Text] [Related]
78. An investigation of the actions of the neuromuscular blocking agent, dipyrandium iodide, on cardiovascular and respiratory function in the horse. Lees P; Tavernor WD Res Vet Sci; 1969 Sep; 10(5):428-34. PubMed ID: 4243172 [No Abstract] [Full Text] [Related]
79. The effect of renal failure and hyperkalemia on the duration of pancuronium neuromuscular blockade in man. Miller RD; Stevens WC; Way WL Anesth Analg; 1973; 52(4):661-6. PubMed ID: 4352150 [No Abstract] [Full Text] [Related]
80. 17-AZASTEROIDS. 3. THE SYNTHESIS OF N-HYDROXY-17A-AZA-D-HOMOSTEROIDS. RAKHIT S; GUT M J Org Chem; 1965 Feb; 30():639-41. PubMed ID: 14267305 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]